Correlation of FDG-PET interpretation with survival in a cohort of glioma patients

Anticancer Research

Volumn 24, Issue 4, 2004, Pages 2359-2365

  Pardo, Francisco S ^a,b,f   Aronen, Hannu J ^a,c   Fitzek, Markus ^a,e   Kennedy, David N ^a   Efird, James ^a,d   Rosen, Bruce R ^a   Fischman, Alan J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e HUMBOLDT UNIVERSITY   (Germany)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain imaging; Central nervous system; Glioma; Tumor progression

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BRAIN METABOLISM; BRAIN TUMOR; CANCER GRADING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DRUG UPTAKE; GLIOMA; GLUCOSE METABOLISM; HUMAN; IMAGE ANALYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; GLIOBLASTOMA; GLIOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SUPRATENTORIAL NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 4444357750     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Shaw EG, Scheithauer BW and O'Fallon JR: Management of supratentorial low-grade gliomas. Sem Rad Oncol 1(1): 23-31, 1991.
2. Spence AM, Muzi M and Krohn KA: Molecular imaging of regional brain tumor biology. J Cell Biochem Suppl 39: 25-35, 2002.
3. Tralins KS, Douglas JG, Stelzer KJ, Mankoff DA, Silbergeld DL, Rostomilly R, Hummel S, Scharnhorst J, Krohn KA and Spence AM: Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation. J Nucl Med 43: 1667-1673, 2002.
4. Schifter T, Hoffman JM, Hanson MW, Boyko OB, Beam C, Paine S, Schold SC, Burger PC and Coleman RE: Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J Comput Assist Tomogr 17: 509-561, 1993.
5. Hawkins RA and Hoh CK: PET FDG studies in oncology. Nucl Med Biol 21: 739-747, 1994.
6. Kim TS, Halliday AL, Hedley-Whyte ET and Convery K: Correlates of survival and the Daumas-Duport grading system for astrocytomas. J Neurosurg 74: 27-37, 1991.
7. Alpert NM, Berdichevsky D, Levin Z, Morris ED and Fischman AJ: Improved methods for image registration. J Neuro Image 3: 10-18, 1996.
8. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
9. Cox DR: Regression models and life-tables. J R Stat Soc Bulletin 34: 187-220, 1993.
10. Therneau TM, Grambsch PM and Fleming TR: Martingale-based residuals and survival models. Biometrika 77: 147-160, 1990.
11. Hochberg FH and Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907-911, 1980.
12. Kelly PJ, Daumas-Duport C, Scheithauer BW and Kispert DB: Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62: 450-459, 1987.
13. Pan DH, Guo WY, Chung WY, Shiau CY, Liu RS and Lee LS: Early effects of Gamma Knife surgery on malignant and benign intracranial tumors. Stereotact Funct Neurosurg 64 Suppl 1: 19-31, 1995.
14. Tralins KS, Douglas JG, Stelzer KJ, Mankoff DA, Silbergeld DL, Rostomilly R, Hummel S, Scharnhorst J, Krohn KA and Spence AM: Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation. J Nucl Med 43: 1667-1673, 2002.
15. Sheline GE, Wara WM and Smith V: Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6: 1215-1228, 1980.
16. Hoshino T, Nagashima T, Murovic J, Levin EM, Levin VA and Rupp SM: Cell kinetics studies of in situ human brain tumors with bromodeoxyuridine. Cytometry 6: 627-632, 1985.
17. Nishioka T, Oda Y, Seino Y, Yamamoto T, Inagaki N, Yano H, Imura H, Shigemoto. R and Kikuchi H: Distribution of the glucose transporters in human brain tumors. Cancer Res 52: 3972-3979, 1992.
18. Muzi M, Freeman SD, Burrows RC, Wiseman RW, Link JM, Krohn KA, Graham MM and Spence AM: Kinetic characterization of hexokinase isoenzymes from glioma cells: implications for FDG imaging of human brain tumors. Nucl Med Biol 28: 107-116, 2001.
19. Muzi M, Freeman SD, Burrows RC, Wiseman RW, Link JM, Krohn KA, Graham MM and Spence AM: Kinetic characterization of hexokinase isoenzymes from glioma cells: implications for FDG imaging of human brain tumors. Nucl Med Biol 28: 107-116, 2001.
20. Burger PC, Rawlinlgs CE, Cox EB, McLendon RE, Schold SC Jr and Bullard DE: Clinicopathologic correlations in the oligodendroglioma. Cancer 59: 1345-1352, 1987.
21. Aronen HJ, Pardo FS, Belliveau JW, Packard SD, Hsu DW, Hochberg FH, Fischman AJ and Rosen BR: High microvascular volume is associated with high glucose uptake and and tumor angiogenesis in human gliomas. Clin Cancer Res 6: 2189-2200, 2000.
22. Pardo FS, Aronen HG, Kennedy D, Skates S, Paiva K, Okunieff P, Schmidt EV, Hochberg FH, Harsh GR, Fischman AJ, Linggood RM and Rosen BR: Functional cerebral imaging in the evaluaton and radiotherapeutic treatment planning of patients with malignant glioma. Int J Rad Onc Biol Phys 30: 663-669, 1994.
23. Spence AM, Muzi M, Graham MM, O'Sullivan F, Link JM, Lewellen TK, Lewellen B, Freeman SD, Mankoff DA, Eary JF and Krohn KA: 2-[(18)F] Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome. Clin Cancer Res 8: 971-979, 2002.
24. Aronen HJ, Gazit EI, Louis DN, Buchbinder BR, Pardo FS, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH and Rosen BR: Cerebral blood volume maps of gliomas: comparison with tumor grade and histological findings. Radiology 191: 41-51, 1994.
25. Tralins KS, Douglas JG, Stelzer KJ, Mankoff DA, Silbergeld DL, Rostomilly R, Hummel S, Scharnhorst J, Krohn KA and Spence AM: Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation. J Nucl Med 43: 1667-1673, 2002.
26. Lee JK, Liu RS, Shiang HR and Pan DH: Usefulness of semiquantitative FDG-PET in the prediction of brain tumor treatment response to gamma knife radiosurgery. J Comput Assist Tomogr 27: 525-529, 2003.
27. Schifter T, Hoffman JM, Hanson MW, B. O. B. C, Pain S, Schold SC, Burger PC and Coleman RE: Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J Comp Asst Tomography 17: 509-561, 1993.
28. Lee JK, Liu RS, Shiang HR and Pan DH: Usefulness of semiquantitative FDG-PET in the prediction of brain tumor treatment response to gamma knife radiosurgery. J Comput Assist Tomogr 27: 525-529, 2003.
29. Di Chiro G and Brooks RA: PET quantitation: blessing and curse. J Nucl Med 29: 1601-1604, 1988.